About Salcaprozate Sodium (SNAC) (Excipient For Oral Semaglutide) API
Therapeutic CategoryOthers
API Technology
Synthetic
Dose Form
Oral Solids
Dr Reddy's Development Status
Available (Commercial)
Mechanism of Action
Salcaprozpate Sodium (SNAC) is an excipient and used as absorption enhancer for delivery of oral Semaglutide
Dr. Reddy's Expertise
Headquartered in Hyderabad, India, Dr. Reddy's Laboratories is one of the leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Salcaprozate Sodium (SNAC) (Excipient For Oral Semaglutide) API. Dr. Reddy's API business is a preferred partner to pharma companies across the US, Europe, Brazil, Latin America, Japan, China, Korea, Middle East and other emerging markets.
Dr. Reddy's API business thrives on the deep technical strengths established over the last 30+ years in the development and manufacture of complex APIs such as steroids, peptides, complex long chain molecules and highly potent APIs (HPAPIs / oncology drugs). This expertise is complemented by our prowess in intellectual property and regulatory affairs which helps us consistently meet and exceed regulatory standards. Dr. Reddy's Salcaprozate Sodium (SNAC) (Excipient For Oral Semaglutide) API is the outcome of the extensive expertise in R&D, IP, and Regulatory.
A key component in helping our customers be first to market is a responsive supply chain. We achieve this by making sure that all our facilities are operating efficiently and to the latest standards of quality, safety, and productivity. A strong interconnect between business and factories allows for a quick reaction to dynamic market changes, so that we can avert shortages and meet sudden surges in demand.
RFQ Form
FAQs
Enhances oral absorption of poorly bioavailable drugs like semaglutide
Available as oral tablets, typically combined with active drugs
Store at room temperature (20°C to 25°C), in a tightly sealed container, away from moisture and light